CBLB

CBLB

Target · E3 ubiquitin ligase

CBLB Cbl proto-oncogene B · E3 ubiquitin-protein ligase CBL-B

CBLB (Cbl proto-oncogene B, also known as Cbl-b or RNF56) is a cytoplasmic RING-finger E3 ubiquitin-protein ligase that tags substrates for proteasomal degradation. It acts as a negative regulator of T-cell, B-cell and high-affinity IgE receptor signalling. Browse Assay Genie's current range of CBLB research reagents below, or read on for the biology behind the target.

Cytoplasmic E3 ligaseNegative regulator of TCR signallingImmunotherapy target
982 aa
Protein length
~109 kDa
Molecular weight
3q13.11
Gene locus
EC 2.3.2.27
Enzyme class
Target information

What is CBLB (cbl proto-oncogene B)?

CBLB is an E3 ubiquitin-protein ligase. It accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes and transfers it to substrates, generally promoting their degradation by the proteasome. It may be functionally coupled with the E2 enzyme UB2D3. The protein negatively regulates the T-cell receptor (TCR), B-cell receptor (BCR) and FCER1 (high-affinity immunoglobulin epsilon receptor) signal transduction pathways.

In naive T-cells, CBLB inhibits VAV1 activation upon TCR engagement and imposes a requirement for CD28 costimulation for proliferation and IL-2 production. It also promotes ubiquitination of PIK3R1/p85, which impairs its recruitment to the TCR. In activated T-cells it inhibits PLCG1 activation and calcium mobilisation upon restimulation and promotes anergy. CBLB is also involved in LAG3-mediated inhibition of TCR signalling: after ligand binding to LAG3, it catalyses 'Lys-63'-linked ubiquitination of LAG3, which releases the LAG3 C-terminus from the membrane and initiates a signal that prevents TCR activation. In B-cells, it ubiquitinates SYK and promotes its proteasomal degradation.

Other reported substrates include SRC, which is slightly ubiquitinated, and EGFR, where CBLB may contribute to ubiquitination and internalisation. In association with CBL, it is required for feedback inhibition of ciliary PDGFRA signalling through ubiquitination and internalisation of the receptor. The CBLB gene belongs to the Cbl proto-oncogene family of RING finger proteins, and earlier names refer to the Cas-Br-M murine ecotropic retroviral transforming sequence b. Studies in mouse suggest the gene is involved in antifungal host defence and that its inhibition increases fungal killing. Manipulating CBLB may be useful for immunotherapies in cancer, autoimmune disease, allergy and infection.

T-cell signalling and anergy

CBLB sets the threshold for TCR activation by requiring CD28 costimulation and promoting anergy, making it central to studies of T-cell tolerance.

Immune checkpoint biology

CBLB ubiquitinates LAG3 after ligand binding, linking this ligase to checkpoint-mediated inhibition of TCR signalling.

Cancer immunotherapy research

Manipulating CBLB may support immunotherapies for cancer, autoimmune disease, allergy and infection, according to the NCBI Gene summary.

Ubiquitin and receptor turnover

CBLB ubiquitinates SYK, PIK3R1 and PDGFRA, and may act on EGFR, providing a model for ligase-directed receptor regulation.

Background

CBLB frequently asked questions

What does CBLB do?

CBLB is an E3 ubiquitin-protein ligase that transfers ubiquitin from E2 enzymes to substrates, generally targeting them for proteasomal degradation. It limits signalling from the T-cell receptor, B-cell receptor and high-affinity IgE receptor, and in T-cells it promotes anergy and requires CD28 costimulation for activation.

What other names does CBLB go by?

CBLB is also written Cbl-b and has the alias RNF56. The UniProt name is E3 ubiquitin-protein ligase CBL-B. Earlier HGNC names refer to the Cas-Br-M (murine) ecotropic retroviral transforming sequence b. It belongs to the Cbl proto-oncogene family of RING finger proteins.

Is CBLB conserved in mouse and linked to disease?

Yes, mouse and rat both have a Cblb ortholog. Mouse studies suggest the gene contributes to antifungal host defence, and its inhibition increases fungal killing. NCBI notes that manipulating CBLB may benefit immunotherapy for cancer, autoimmune diseases, allergies and infections. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other Cbl family members, TCR and BCR signalling proteins, checkpoint receptors and ubiquitin pathway partners with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13191; product specifications from Assay Genie datasheets.

CBLB Product listing